Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Cancer Resectable

Clinical trial condition

Pancreatic Cancer Resectable

Explore clinical trials studying Pancreatic Cancer Resectable. Study availability and eligibility vary by location and protocol.

31 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Cancer Resectable trial results

Not Yet Recruiting

Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers

NCT06703905

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

NCT06670547

Conditions: Adenocarcinoma, Bile Duct Diseases, Biliary Fistula, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures

NCT06495749

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease, +9 more
Locations: First Affiliated Hospital, Medical College of Zhejiang University Hangzhou, Zhejiang, China

the First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head

NCT05637567

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations: Not specified

View Trial Details

Completed

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

NCT07184047

Conditions: Atrophy, Biliary Tract Cancer, Biliary Tract Diseases, +53 more
Locations: Etlik City Hospital, Medical Oncology Department Ankara, Yenimahalle, Turkey (Türkiye)

View Trial Details

Completed

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

NCT06809374

Conditions: Pancreatic Cancer Resectable
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.

NCT04224402

Conditions: Pancreatic Cancer Resectable
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

NCT05483257

Conditions: Disease Attributes, Pancreatic Cancer Resectable, Pathologic Processes, +2 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

NCT07157605

Conditions: Pancreatectomy, Pancreatic Cancer Resectable
Locations: BenQ Hospital Nanjing, China

Konstantopoulio General Hospital Athens, Greece

Padova University Hospital Padova, Italy

Kyushu University Hospital Fukuoka, Japan

View Trial Details

Active, Not Recruiting

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

NCT05479708

Conditions: Neoplasm, Residual, Neoplasms, Neoplastic Processes, +3 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details